Antimicrobial Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: A7F96ABE602AEN
Market Monitor Global

Abstracts

An antimicrobial is an agent that kills microorganisms or stops their growth.

This report contains market size and forecasts of Antimicrobial Therapeutics in Global, including the following market information:

Global Antimicrobial Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antimicrobial Therapeutics market was valued at 205650 million in 2021 and is projected to reach US$ 274130 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hospital Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antimicrobial Therapeutics include Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc. and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antimicrobial Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antimicrobial Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antimicrobial Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Hospital
• Clinic
• Personal
• Other

Global Antimicrobial Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antimicrobial Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Antiviral
• Antibacterial
• Antifungal
• Antiparasitic

Global Antimicrobial Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antimicrobial Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antimicrobial Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antimicrobial Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Merck & Co Inc.
• Pfizer Inc.
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antimicrobial Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antimicrobial Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIMICROBIAL THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Antimicrobial Therapeutics Market Size: 2021 VS 2028
2.2 Global Antimicrobial Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antimicrobial Therapeutics Players in Global Market
3.2 Top Global Antimicrobial Therapeutics Companies Ranked by Revenue
3.3 Global Antimicrobial Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antimicrobial Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antimicrobial Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antimicrobial Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Antimicrobial Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antimicrobial Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antimicrobial Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Hospital
  4.1.3 Clinic
  4.1.4 Personal
  4.1.5 Other
4.2 By Type - Global Antimicrobial Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Antimicrobial Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Antimicrobial Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antimicrobial Therapeutics Market Size, 2021 & 2028
  5.1.2 Antiviral
  5.1.3 Antibacterial
  5.1.4 Antifungal
  5.1.5 Antiparasitic
5.2 By Application - Global Antimicrobial Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Antimicrobial Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Antimicrobial Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antimicrobial Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Antimicrobial Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Antimicrobial Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Antimicrobial Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antimicrobial Therapeutics Revenue, 2017-2028
  6.3.2 US Antimicrobial Therapeutics Market Size, 2017-2028
  6.3.3 Canada Antimicrobial Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Antimicrobial Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antimicrobial Therapeutics Revenue, 2017-2028
  6.4.2 Germany Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.3 France Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.5 Italy Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.6 Russia Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Antimicrobial Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Antimicrobial Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antimicrobial Therapeutics Revenue, 2017-2028
  6.5.2 China Antimicrobial Therapeutics Market Size, 2017-2028
  6.5.3 Japan Antimicrobial Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Antimicrobial Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Antimicrobial Therapeutics Market Size, 2017-2028
  6.5.6 India Antimicrobial Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antimicrobial Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Antimicrobial Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Antimicrobial Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antimicrobial Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Antimicrobial Therapeutics Market Size, 2017-2028
  6.7.3 Israel Antimicrobial Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Antimicrobial Therapeutics Market Size, 2017-2028
  6.7.5 UAE Antimicrobial Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead Sciences, Inc.
  7.1.1 Gilead Sciences, Inc. Corporate Summary
  7.1.2 Gilead Sciences, Inc. Business Overview
  7.1.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Major Product Offerings
  7.1.4 Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Gilead Sciences, Inc. Key News
7.2 GlaxoSmithKline plc
  7.2.1 GlaxoSmithKline plc Corporate Summary
  7.2.2 GlaxoSmithKline plc Business Overview
  7.2.3 GlaxoSmithKline plc Antimicrobial Therapeutics Major Product Offerings
  7.2.4 GlaxoSmithKline plc Antimicrobial Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline plc Key News
7.3 Merck & Co Inc.
  7.3.1 Merck & Co Inc. Corporate Summary
  7.3.2 Merck & Co Inc. Business Overview
  7.3.3 Merck & Co Inc. Antimicrobial Therapeutics Major Product Offerings
  7.3.4 Merck & Co Inc. Antimicrobial Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Merck & Co Inc. Key News
7.4 Pfizer Inc.
  7.4.1 Pfizer Inc. Corporate Summary
  7.4.2 Pfizer Inc. Business Overview
  7.4.3 Pfizer Inc. Antimicrobial Therapeutics Major Product Offerings
  7.4.4 Pfizer Inc. Antimicrobial Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Inc. Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Antimicrobial Therapeutics Major Product Offerings
  7.5.4 Sanofi Antimicrobial Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antimicrobial Therapeutics Market Opportunities & Trends in Global Market
Table 2. Antimicrobial Therapeutics Market Drivers in Global Market
Table 3. Antimicrobial Therapeutics Market Restraints in Global Market
Table 4. Key Players of Antimicrobial Therapeutics in Global Market
Table 5. Top Antimicrobial Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antimicrobial Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antimicrobial Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antimicrobial Therapeutics Product Type
Table 9. List of Global Tier 1 Antimicrobial Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antimicrobial Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antimicrobial Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antimicrobial Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antimicrobial Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antimicrobial Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antimicrobial Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antimicrobial Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antimicrobial Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antimicrobial Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antimicrobial Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antimicrobial Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antimicrobial Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antimicrobial Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antimicrobial Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antimicrobial Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Sciences, Inc. Corporate Summary
Table 31. Gilead Sciences, Inc. Antimicrobial Therapeutics Product Offerings
Table 32. Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline plc Corporate Summary
Table 34. GlaxoSmithKline plc Antimicrobial Therapeutics Product Offerings
Table 35. GlaxoSmithKline plc Antimicrobial Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Merck & Co Inc. Corporate Summary
Table 37. Merck & Co Inc. Antimicrobial Therapeutics Product Offerings
Table 38. Merck & Co Inc. Antimicrobial Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Inc. Corporate Summary
Table 40. Pfizer Inc. Antimicrobial Therapeutics Product Offerings
Table 41. Pfizer Inc. Antimicrobial Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Antimicrobial Therapeutics Product Offerings
Table 44. Sanofi Antimicrobial Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antimicrobial Therapeutics Segment by Type in 2021
Figure 2. Antimicrobial Therapeutics Segment by Application in 2021
Figure 3. Global Antimicrobial Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antimicrobial Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antimicrobial Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antimicrobial Therapeutics Revenue in 2021
Figure 8. By Type - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antimicrobial Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antimicrobial Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline plc Antimicrobial Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck & Co Inc. Antimicrobial Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Inc. Antimicrobial Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Antimicrobial Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)